{"id":"W2140821882","doi":"10.3899/jrheum.130489","title":"Continued Benefit of Tocilizumab Plus Disease-modifying Antirheumatic Drug Therapy in Patients with Rheumatoid Arthritis and Inadequate Clinical Responses by Week 8 of Treatment","year":2014,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Agency for Healthcare Research and Quality; National Institutes of Health; F. Hoffmann-La Roche; Amgen; Bristol-Myers Squibb; Abbott Laboratories","keywords":"Medicine; Tocilizumab; Rheumatoid arthritis; Placebo; Internal medicine; Randomized controlled trial; Gastroenterology; Arthritis; Surgery; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003609458,0.0003130933,0.001771605,0.00032008,0.0002685023,0.0004243082,0.0001973641,0.0005379925,0.0009143314],"category_scores_gemma":[0.00494943,0.0001983457,0.000842752,0.0002703539,0.0002561549,0.0004633298,0.0002505283,0.0006561133,0.0001224945],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003044002,"about_ca_system_score_gemma":0.0004395397,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000377341,"about_ca_topic_score_gemma":0.001046722,"domain_scores_codex":[0.9981639,0.001101487,0.0002132792,0.0001623551,0.0002061102,0.0001529959],"domain_scores_gemma":[0.9952884,0.002333259,0.001286294,0.0002717348,0.0002183429,0.0006020822],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4413427,0.00245054,0.4046386,0.0007828637,0.004030866,0.0005405202,0.0002395764,0.0009441258,0.01326213,0.0001127972,0.0007914723,0.1308639],"study_design_scores_gemma":[0.02893841,0.1094707,0.8502601,0.0001428972,0.003341296,0.001150348,0.0001170398,0.002165371,0.001962913,0.0001982727,0.002208162,0.00004435371],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938117,0.005276516,0.0001909552,0.00014643,0.00002810659,0.00006362311,0.00009049974,0.00001164991,0.0003804593],"genre_scores_gemma":[0.9991007,0.0002814049,0.0002126649,0.0001268945,0.00005287179,0.00003386962,0.0001054425,0.000001564963,0.00008460508],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003609458,"threshold_uncertainty_score":0.01908892,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01923816869254608,"score_gpt":0.2863745168756803,"score_spread":0.2671363481831343,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}